Latest updates for Endo/Mallinckrodt

Fresh curated links around Endo/Mallinckrodt are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and Unite
  • Chemical Structure, Formula, and Name Support Written Description of Pharmaceutical Genus
  • <![CDATA[ Eli Lilly to Acquire Merida Biosciences for $2.8 Billion ]]>

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

orthotw.com /2 weeks ago

Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and Unite...

Pacira BioSciences today announced a strategic partnership with Molteni Farmaceutici to expand access to opioid-sparing postsurgical pain management across European markets.

Read source
natlawreview.com /1 month ago

Chemical Structure, Formula, and Name Support Written Description of Pharmaceutical Genus

Read source
pharmexec.com /1 month ago

&lt;![CDATA[ Eli Lilly to Acquire Merida Biosciences for $2.8 Billion ]]&gt;

Read source
pharmexec.com /4 days ago

&lt;![CDATA[METiS Enters Collaboration with Eli Lilly for Next-Generation Tissue-Specific LNP Delivery Technologies]]&gt...

Read source
cafepharma.com /1 month ago

Sun to acquire Organon

Sun to acquire Organon Anonymous (not verified) Sun, 08/30/2026 - 09:43 field_thread_url https://cafepharma.com/boards/threads/sun-to-acquire-organon.71639...

Read source
pharmexec.com /2 weeks ago

&lt;![CDATA[Viatris Acquires Pacira BioSciences for $1.65 Billion ]]&gt;

Read source
pharmexec.com /3 weeks ago

&lt;![CDATA[Pharmaceutical Executive Daily: Merck Acquires SPR2015 in $2.13 Billion Licensing Deal]]&gt;

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Endo/Mallinckrodt

cafepharma.com

Recent coverage from public sources
Public source

natlawreview.com

Recent coverage from public sources
Public source

ryortho.com

Recent coverage from public sources
Public source

pharmexec.com

Recent coverage from public sources
Public source